Functional Ingredients: Effect in Gastrointestinal System

June 15, 2015 updated by: Eliana Bistriche Giuntini, University of Sao Paulo

Functional Ingredients: Effect in Satiety and Intestinal Health

The addition of fructans or unripe banana flour to frozen meals can change the hormonal parameters related to hunger and satiety, improve the bowel movements and increase in colonic bacteria population measured by microbiological determinations (qPCR). The inulin no can change bowel movements and increase in colonic bacteria population measured by microbiological determinations (qPCR)

Study Overview

Detailed Description

Non-transmissible chronic diseases have been constantly related to the consumption of diets with inadequate nutrient input; at the same time, the ingestion of unavailable carbohydrates have presented an inverse relationship with the risk for these diseases. Among these carbohydrates is inulin, a fructan considered as a prebiotic and the unripe banana flour, rich in resistant starch, which may contribute to the intestinal health.

This study evaluated the effect of regular intake of frozen soups added functional ingredients (fructans and unripe banana flour) by heath volunteers, about gastrointestinal hormones, satiety and bowel movements.

Study Type

Interventional

Enrollment (Actual)

61

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Sao Paulo, Brazil, 05508000
        • Faculty of Pharmaceutical Sciences USP

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

- good health condition

Exclusion Criteria:

  • history of renal or gastrointestinal disease
  • hyperthyroidism
  • diabetes, nor parents with diabetes
  • for women: not pregnant, breastfeeding or using hormonal therapy
  • using any drug that might affect the digestion of food and absorption (antibiotics, laxatives)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: UBF group
Ready-to-eat frozen soups added unripe banana flour (18 portions; 3 times/week)
Ready-to-eat frozen soups added unripe banana flour (18 portions; 3 times/week)
Placebo Comparator: Control
Ready-to-eat frozen soups added maltodextrin (18 portions; 3 times/week)
Ready-to-eat frozen soups added maltodextrin (18 portions; 3 times/week)
Experimental: Inulin group
Ready-to-eat frozen soups added inulin (18 portions; 3 times/week)
Ready-to-eat frozen soups added inulin (18 portions; 3 times/week)
Experimental: Nisin group
Ready-to-eat frozen soups added nisin (18 portions; 3 times/week)
Ready-to-eat frozen soups added nisin (18 portions; 3 times/week)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in hormonal parameters related to hunger and satiety.
Time Frame: 6 weeks
Changes in satiety measured by specific hormones kit
6 weeks
Change in bowel function
Time Frame: 6 weeks
Changes measured by GSRS and daily questionnaires
6 weeks
Change in colonic bacteria population
Time Frame: 6 weeks
Changes measured by microbiological analysis by r16SDNA sequencing
6 weeks
Change in satiety
Time Frame: 6 weeks
Changes in satiety measured by Visual Analogue Scale questionnaire.
6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in biochemical parameters
Time Frame: 6 weeks
Changes measured by biochemical kit
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Elizabete W Menezes, Prof Assoc, Faculty of Pharmaceutical Sciences of University of Sao Paulo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2012

Primary Completion (Actual)

August 1, 2012

Study Completion (Actual)

December 1, 2012

Study Registration Dates

First Submitted

June 3, 2015

First Submitted That Met QC Criteria

June 5, 2015

First Posted (Estimate)

June 10, 2015

Study Record Updates

Last Update Posted (Estimate)

June 17, 2015

Last Update Submitted That Met QC Criteria

June 15, 2015

Last Verified

June 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • CEPFCF194 CEPFCF18
  • CONEP Brasil (Registry Identifier: CAAE 0069.0.018.198-11)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes

Clinical Trials on Ready-to-eat frozen soups added unripe banana flour

Subscribe